Showing results (711-720 of 985) with videos related to
Sort By:
Pageof 99
The American Journal on Addictions|February 26, 2025
The 24-year course of substance use disorders in patients with borderline personality disorder and personality-disordered comparison subjectsMary C Zanarini, Christina M Temes, Isabel V Glass, et al.Journal of Biomedical Optics|February 2, 2011
Multimodal spectroscopy detects features of vulnerable atherosclerotic plaqueObrad R Sćepanović, Maryann Fitzmaurice, Arnold Miller, et al.Statistics in Medicine|February 24, 1999
Goodness-of-fit for GEE: an example with mental health service utilizationN J Horton, J D Bebchuk, C L Jones, et al.Clinical and Translational Medicine|June 19, 2013
A pilot study demonstrating a non-invasive method for the measurement of protein turnover in skin disorders: application to psoriasisClaire L Emson, Sarah Fitzmaurice, Glen Lindwall, et al.BMC Family Practice|September 19, 2003
SMART: self-management of anticoagulation, a randomised trial [ISRCTN19313375]Deborah McCahon, David A Fitzmaurice, Ellen T Murray, et al.International Journal of Chronic Obstructive Pulmonary Disease|June 29, 2018
Clinical characteristics of patients newly diagnosed with COPD by the fixed ratio and lower limit of normal criteria: a cross-sectional analysis of the TargetCOPD trialMartin R Miller, Shamil Haroon, Rachel E Jordan, et al.Addiction (Abingdon, England)|November 19, 2010
The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up studyMary C Zanarini, Frances R Frankenburg, Frances R Frankenbur, et al.Family Practice|April 15, 2014
Is screening for AF worthwhile? Stroke risk in a screened population from the SAFE studyD A Fitzmaurice, D McCahon, J Baker, et al.Free Radical Biology & Medicine|February 5, 2016
Do glutathione levels decline in aging human brain?Junchao Tong, Paul S Fitzmaurice, Anna Moszczynska, et al.The Journal of Clinical Psychiatry|January 7, 2015
Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent populationKatherine A McDermott, Margaret L Griffin, Hilary S Connery, et al.Pageof 99